Work

Biomarker-Based Drug Development in NSCLC

Year: 2012

Type: article

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)31940-2

Author: P.A. Jänne

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999558268

FWCI:

Cites:

Cited by:

Related to: 10